 |
|
|
| |
Characterization of HIV/HBV Co-infected Participants Achieving High Rates of Hepatitis B Surface
Antigen (HBsAg) Loss in the ALLIANCE Phase 3 Clinical Study
|
| |
| |
AASLD 2025 Nov 7-11 Wash DC
Caleb D Marceau 1, Pamela M Odorizzi1, Nikita S Kolhatkar1, Thomas Aeschbacher1, David Pan1, June Mung1, Sophia Rahman1, Michelle L. D'Antoni1, Ross Martin1, Scott Balsitis1, Sharline Madera1, Frida Abramov1, Jason Hindman1, Hongmei Mo1, Anchalee Avihingsanon2
1Gilead Sciences Inc., Foster City, CA, USA
2 Thai Red Cross AIDS Research Centre, Bangkok Thailand; Chulalongkorn University, Bangkok Thailand
|
| |
|
|
|
|
|
